Get informed when a big investor buys or sells
+ FollowOvervalued by 105.7% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $82.04 Million |
|---|---|
| Enterprise Value | $77.80 Million |
| Earnings per Share | $-0.03 |
| Beta | 1.24 |
| Outstanding Shares | 67,826,080 |
| P/E Ratio | -7.76 |
|---|---|
| PEG | -10.63 |
| Price to Sales | - |
| Price to Book Ratio | -1.12 |
| Enterprise Value to Revenue | 35.69 |
| Enterprise Value to EBIT | -5.29 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | -0.21 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
AB Science S.A. is a pharmaceutical firm focused on discovering, advancing, and commercializing protein kinase inhibitors for both human and animal therapeutic applications. The company's primary drug candidate, masitinib, a tyrosine kin...